Medicine

Sanofi And Regeneron To Increase Praluent Accessibility For High-Risk Patients

Sanofi And Regeneron To Increase Praluent Accessibility For High-Risk Patients

The new price will be in alignment with a value assessment for this population from the Institute for Clinical and Economic Review (ICER).

A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often.

Long-awaited data from the 18,924 patient ODYSSEY OUTCOMES trial, announced at the American College of Cardiology's annual conference in Orlando, showed the study met its primary outcome. Praluent was also associated with a lower risk of death overall, known as "all-cause mortality", and there were also numerically fewer coronary heart disease (CHD) deaths.

After almost three years, 9.5 percent of those on Praluent and 11.1 percent of those on dummy medicine had suffered a heart attack, stroke, heart-related death or serious chest pain; 3.5 percent on Praluent and 4.1 percent on dummy medicine died.

Praluent significantly reduced risk of major adverse cardiovascular events (MACE) in patients who had suffered a recent acute coronary syndrome event such as a heart attack.

In a post-hoc analysis of this group, Praluent was associated with a lower risk of death from any cause by 29%.

Regeneron and Sanofi said on Saturday they would lower the net price of Praluent if onerous barriers to its access are removed for the highest-risk patients.

"Not all patients with heart disease are the same". "Because the treatment effect was so much more marked in the patients with the highest LDL cholesterol, we believe that these patients are the optimal candidates for therapy". The drugs have been sold since 2015 but cost more than $14,000 a year, and insurers have balked at paying without proof that they reduce health problems, not just the cholesterol number.




ICER's latest analysis sets a value-based price range of $4,500-8,000 per year, net of rebates and discounts, for this group, and the companies have said they will offer discounts of up to 69% to health insurers that reduce prescribing obstacles and will be meeting with United States health plans to discuss pricing adjustments. He says Amgen (AMGN -0.9%) would have to cut the price on Repatha (evolocumab) even more to grab market share.

"It may take years and years to really reap all the benefits that one can achieve", study co-chairman Dr. Gregory Schwartz said.

Sanofi also seems to have won over the doctors attending the conference, which will help it in the coming months as the battle with Amgen begins in earnest.

There were no new safety signals in the trial, with injection site reactions experienced more commonly in the Praluent group compared to patients on maximally-tolerated statins alone.

All patients randomly received Praluent or a placebo and were treated for an average (median) of 2.8 years, with some patients being treated for up to five years.

With an LDL target range of 25-50, rather than taking it as low as possible, three-quarters of patients ended up on a lower dose of Praluent and some were taken off the drug if their LDL remained at 15 or lower. They had LDL cholesterol at 70 mg/dL or above and non-HDL cholesterol 100 mg/dL or above. Management sees population of 300K - 400K high-risk patients in USA, only 38K being treated at present.

Data showed 730 patients stopped receiving Praluent while on the 75mg dose after experiencing two consecutive LDL-C measurements below 15 mg/dL while on the 75 mg dose.


  • Delegation from Syria rebel enclave mulls evacuation deal

    Delegation from Syria rebel enclave mulls evacuation deal

    He says Turkish troops have destroyed water and power stations that supply the town of Afrin, making it hard for people to stay. Pro-government forces had also captured the town of Misraba one day earlier.
    Bluepoint's next game is another remake

    Bluepoint's next game is another remake

    For those who have had the chance to play the Shadow of Colossus then they will certainly be enjoying the upcoming next remake. They have aims to improve the art pipeline as well as improving the engine, the workflow of artists and such.
    AB de Villiers opens up about special ton

    AB de Villiers opens up about special ton

    De Villiers made batting look outrageously easy but he insisted it was anything but, especially when he approached three figures. Among South Africans, only Dale Steyn has more ten-fors than Rabada, but his five have taken 86 Tests.
  • Ted Cruz ad mocks challenger O'Rourke for going by 'Beto'

    Ted Cruz ad mocks challenger O'Rourke for going by 'Beto'

    However, what bothers Colbert the most about the song was how it rhymes "man" with "man" right there at the start. It also says he "changed his name to Beto".

    Investors Catching Stocks Cisco Systems, Inc. (CSCO)

    Moreover, Bard has 0.57% invested in CCUR Holdings, Inc. (NASDAQ:CSCO) has "Buy" rating given on Monday, February 12 by Nomura. Webster Bank increased Bank Of America Corp (NYSE:BAC) stake by 24,289 shares to 200,193 valued at $5.07M in 2017Q3.
    Timo Werner rules out Manchester United, Liverpool move

    Timo Werner rules out Manchester United, Liverpool move

    Werner is one of Europe's hottest properties after shining for RB Leipzig since joining the Bundesliga side in 2016. Werner has so far managed 10 Bundesliga goals this season, while bagging another 6 in European competitions.
  • Tim Berners-Lee says regulation of the Web may be needed

    Tim Berners-Lee says regulation of the Web may be needed

    Berners-Lee is concerned about the fact that a small "handful of platforms control which ideas and opinions are seen and shared". At the current rate the internet inventor says that the last billion will only be connected to the internet by 2042.
    Apple is buying the 'Netflix for magazines' company

    Apple is buying the 'Netflix for magazines' company

    Magazines carried on Texture include GQ, National Geographic, Vanity Fair , Wired and The Atlantic. The move marks Apple's second reported acquisition of the calendar year.
    Andrew Liveris stepping down as DowDuPont executive chairman

    Andrew Liveris stepping down as DowDuPont executive chairman

    The committee also said it will appoint Howard Ungerleider as president and chief financial officer of the division. He told the Wall Street Journal this is the right time to leave, with stocks hitting an all time high.
  • Snapchat, Instagram remove Giphy integration due to racist GIF

    Snapchat, Instagram remove Giphy integration due to racist GIF

    It has also revealed that it was a bug that went unnoticed and allowed that particular GIF to appear on Snapchat and Instagram. However, things can slip as Giphy operates like search engine in which one the web's top GIFs get indexed.
    Salma Hayek: How Could They Turn Frida Kahlo Into a Barbie?

    Salma Hayek: How Could They Turn Frida Kahlo Into a Barbie?

    Pablo Sangri, a lawyer for the family, said his client didn't seek money, but wanted Mattel to talk about redesigning. Kahlo was known for her assertive embrace of her Mexican identity and her unabashed, unmanicured femininity.
    Wanyama's Tottenham hammer Bournemouth to go third on the EPL standings

    Wanyama's Tottenham hammer Bournemouth to go third on the EPL standings

    This puts us in good stead for the remainder of the season, a top-four finish and an FA Cup trophy to add would be the icing on the cake now.